X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
BIOCON LTD Announces Quarterly Results (4QFY18); Net Profit Up 19.8%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON LTD Announces Quarterly Results (4QFY18); Net Profit Up 19.8%
Fri, 20 Jul

BIOCON LTD has announced its results for the quarter ended March 2018. Here is a detailed performance review of the same:

BIOCON LTD Quarterly Financials

No. of Mths
Qtr. Ending
3
Mar-17*
3
Dec-17*
3
Mar-18*
QoQ ChangeYoY Change
Net SalesRs m9,31110,57911,69510.5%25.6%
Other incomeRs m43233967599.1%56.3%
TurnoverRs m9,74310,91812,37013.3%27.0%
ExpensesRs m7,4368,3629,36512.0%25.9%
Gross profitRs m1,7212,0002,38119.1%38.3%
DepreciationRs m725974953-2.2%31.4%
InterestRs m5014716915.0%238.0%
Profit before taxRs m1,3781,2181,93458.8%40.3%
TaxRs m10336140712.7%295.1%
Profit after taxRs m1,2758571,52778.2%19.8%
Gross profit margin%18.518.920.4
Effective tax rate%7.529.621.0
Net profit margin%13.17.812.3
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 25.6% on a year-on-year (YoY) basis. The expenses were up by 25.9% YoY during the same period.
  • The company's operating profit increased by 38.3% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 20.4% in 4QFY18 as against 18.5% in 4QFY17.
  • Depreciation charges and finance costs increased by 31.4% YoY and 238.0% YoY, respectively.
  • Other income increased by 56.3% YoY during the quarter.
  • Net profit for the quarter increased by 19.8% YoY. Net profit margins during the quarter declined from 13.1% in 4QFY17 to 12.3% in 4QFY18.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 10.5% on a quarter-on-quarter (QoQ) basis. The expenses were up by 12.0% QoQ during the same period.
  • The company's operating profit increased by 19.1% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 20.4% in 4QFY18 as against 18.9% in 3QFY17.
  • Net profit for the quarter increased by 78.2% QoQ, while net profit margins increased from 7.8% in 3QFY17 to 12.3% in 4QFY18.

To see how BIOCON LTD has performed over the last eight quarters, please visit here.

BIOCON LTD Share Price Performance

Over the last one year, BIOCON LTD share price has moved up from Rs 403.9 to Rs 583.0, registering a Gain of Rs 179.1 or around 44.3%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,611.1 (up 0.7%). Over the last one year it has moved down from 14,918.1 to 13,611.1, a gain of -1,307.0 points (down 8.8%).

Overall, the S&P BSE SENSEX is up 0.4% over the year.

Current Valuations

At the current price of Rs 583.0, the price to earnings (P/E) ratio of BIOCON LTD stands at 88.6 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 7.2 times.

Equitymaster requests your view! Post a comment on "BIOCON LTD Announces Quarterly Results (4QFY18); Net Profit Up 19.8%". Click here!

  

Related Views on News

BIOCON Announces Quarterly Results (4QFY19); Net Profit Down 53.8% (Quarterly Result Update)

Apr 26, 2019 | Updated on Apr 26, 2019

For the quarter ended March 2019, BIOCON has posted a net profit of Rs 705 m (down 53.8% YoY). Sales on the other hand came in at Rs 8 bn (down 34.7% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON LTD Announces Quarterly Results (3QFY19); Net Profit Up 169.2% (Quarterly Result Update)

Jan 28, 2019 | Updated on Jan 28, 2019

For the quarter ended December 2018, BIOCON LTD has posted a net profit of Rs 2 bn (up 169.2% YoY). Sales on the other hand came in at Rs 15 bn (up 45.6% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

These 3 Smallcap Stocks are Set to Make the Most of Smallcap Rebound(Profit Hunter)

Jul 9, 2019

As the sense of normalcy returns to the markets, the rebound in the quality smallcaps could be huge.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On...(The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

After Disappointing Budget, Here's a Document that Concerns Largecap and Smallcap Investors(The 5 Minute Wrapup)

Jul 8, 2019

A new 'definition' of the stock universe that triggered the smallcap sell-off is back with the latest list...

Here's What to Do with Falling Small Cap Stocks(Profit Hunter)

Jul 10, 2019

There are some great buying opportunities in the market right now - and the small cap space is your best bet.

Budget an Icing on the Cake for This Smart Money Backed Affordable Housing Stock(The 5 Minute Wrapup)

Jul 10, 2019

Affordable housing is one of the most straightforward growth stories in India. This will help the real estate sector to come out of the slump.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON SHARE PRICE


Jul 19, 2019 (Close)

TRACK BIOCON

BIOCON - ASTRAZENECA PHARMA COMPARISON

COMPARE BIOCON WITH

MARKET STATS